Press monitoring
Yttrium-90 to control hepatocarcinoma
29.7.2006 | Press monitoring
The University Hospital at the University of Navarra is the only centre throughout the entire Spanish state for the treatment of liver tumours by means of radioembolisation and the one with the greatest accumulated experiences in the treatment throughout Europe. The technique consists of injecting spheres marked with Yttrium-90 – of very few...
Rules rule
29.7.2006 | Press monitoring
Regulatory affairs is a young profession that's already making its mark in the world of drug development, where one false move can bring years of research to an unwelcome end. If your skills include communication and leadership, it may be for you, says Hannah Hoag.
New report provides analysis on biodefense sector growth
28.7.2006 | Press monitoring
The Biodefense Market Report 2006: Vaccines, Therapeutics and Diagnostics for Bioterror Agents is the definitive study on the state of the biodefense industry. Written by the independent consulting firm BioAbility and published by the editors of BioWorld Today, this report is the only complete resource available providing hard data and information...
Resource sector overshadows Biotechs
28.7.2006 | Press monitoring
The overwhelming interest in resource stocks on the Australian Stock Exchange (ASX) has overshadowed the nation's biotechnology sector, new research shows.
Biology-Oriented Synthesis (BIOS): from natural product to new therapeutics
28.7.2006 | Press monitoring
Natural product based concept for the synthesis of new active agents yields first results Phosphatases are key regulators of various life processes. As a result, many different scientists are looking at them to find treatments for diseases like diabetes and cancer. Researchers still have only a basic knowledge of phosphatases, but are...
Next up for biotech: Virus-resistant trees
27.7.2006 | Press monitoring
Washington, D.C. - When a virus was discovered in Jim Lerew's Pennsylvania peach orchard in 1999, all 160 acres of trees had to be destroyed.
The Immune Cells with the Built-In Blocker
27.7.2006 | Press monitoring
Researchers in Braunschweig have tracked down a natural inhibitor mechanism in our immune system. The molecule, known as GPR83, can block over-reactions by our immune system's defenses before these damage body tissues, according to scientists at the German Research Centre for Biotechnology (GBF). GPR83 manages to do this by switching immune cells...
New Hope for Alzheimer's
26.7.2006 | Press monitoring
Human trials are set to begin next month on a drug that some researchers say could eventually lead to a cure for at least some forms of Alzheimer's disease. The drug, known as PBT2, stopped the disease in mice, according to Australian researchers.
How Dangerous Is My Science?
26.7.2006 | Press monitoring
How can biomedical researchers tell whether their work might be misused by terrorists? A U.S. government-appointed panel has come up with some broad guidance on the question and suggested that in some cases, scientists should not publish the results of such "dual-use" research.
World-first stem cell research could aid male infertility
26.7.2006 | Press monitoring
Scientists have shown for the first time that sperm grown from embryonic stem cells can be used to produce offspring.
